It’s Time to Put Guardrails on GLP-1 Compounding
Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and…
Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products. The post It’s Time to Put Guardrails on GLP-1 Compounding appeared first on MedCity News.
This factsheet discusses HPV and related cancers, use of the HPV vaccines for both females and males, and insurance coverage and access to the vaccines.
[Sponsored] Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems. The post The Power Behind Enterprise EHR Software for Large Healthcare Systems appeared first on MedCity News.
The Trump administration is quietly seeking unprecedented access to medical records for millions of federal workers and retirees, and their families. A brief notice from the Office of Personnel Management could dramatically change which personally identifiable medical information the agency obtains, giving it the power to see prescriptions employees had filled or what treatment they…
MARQUETTE, Mich. — Providing abortions was the last thing Shawn Brown thought she’d be doing when she opened an urgent care clinic in this remote town in Michigan’s Upper Peninsula. But she also wasn’t expecting the Planned Parenthood in Marquette to shut down last spring. Roughly 1,100 patients relied on that clinic each year for…
Healthcare leaders can’t tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven’t delivered measurable savings and point to direct contracting as a more transparent way to control spending. The post Do Healthcare CEOs Agree on Whether VBC and…
Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas. The post Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis appeared first on MedCity News.
El médico de familia Eric Boose ha estado usando una herramienta de inteligencia artificial (IA) para volver a lo que él llama la “medicina a la antigua”: hablar con los pacientes cara a cara, sin tener que escribir en una computadora al mismo tiempo. “Realmente puedo sentarme, interactuar, concentrarme en ellos y escuchar”, dijo Boose,…
When revenue cycle partners wait to be asked, or rely on “tell us what you need” as a default, they miss critical opportunities to deliver meaningful performance, support their client organizations, and ultimately serve patients better. In today’s healthcare environment, partnership requires anticipation, not reaction. The post Stop Waiting to Be Asked: What Operators Really…
Today’s technology has the potential to empower independent pharmacies to offer adherence support at a greater scale — and healthcare engagements that overlook this touchpoint miss out. The post How Tech-Enabled Independent Pharmacies Can Address America’s Medication Adherence Crisis appeared first on MedCity News.